Systematic Review
Accepted on 03 Apr 2025
Bispecific Antibodies Combined with Chemotherapy in Solid Tumor Treatment, the Path Forward?
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1568724
Type at least 3 characters
7,540 articles
Original Research
Published on 03 Apr 2025
Neoantigen peptide-pulsed dendritic cell vaccine therapy after surgical treatment of pancreatic cancer: a retrospective study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1571182
- 993 views
Systematic Review
Published on 03 Apr 2025
Pulmonary fibrosis complicated by lung cancer: bibliometric analysis from 2004 to 2024 - research status, trends and future directions
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1514831
- 674 views
Review
Published on 03 Apr 2025
The role of autophagy in cancer: from molecular mechanism to therapeutic window
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1528230
- 1,020 views
Original Research
Published on 03 Apr 2025
Cuproptosis-related gene ACAD8 inhibits the metastatic ability of colorectal cancer by inducing cuproptosis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1560322
- 519 views
Original Research
Published on 03 Apr 2025
Exhaled breath analysis with the use of an electronic nose to predict response to immune checkpoint inhibitors in patients with metastatic melanoma: melaNose trial
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1564463
- 404 views
Review
Published on 03 Apr 2025
Benign non-immune cells in tumor microenvironment
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1561577
- 603 views
Original Research
Published on 03 Apr 2025
Cadonilimab plus chemotherapy as first-line treatment for persistent, recurrent, or metastatic cervical cancer: a cost-effectiveness analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1562875
- 562 views
Methods
Published on 03 Apr 2025
Nucleofection-based screening of chimeric antigen receptor candidates in human natural killer cells
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1557766
- 802 views
Review
Accepted on 02 Apr 2025
Role and Mechanisms of Exercise Therapy in Enhancing Drug Treatment for Glioma: A Review
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1576283
Review
Accepted on 02 Apr 2025
Long non-coding RNAs as Key Modulators of the Immune Microenvironment in Hepatocellular Carcinoma: Implications for Immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1523190
Review
Accepted on 02 Apr 2025
Tissue-Resident Immune Cells in Cervical Cancer: Emerging Roles and Therapeutic Implications
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1541950
Original Research
Accepted on 02 Apr 2025
Ubiquitination and ALL: Identifying FBXO8 as a Prognostic Biomarker and Therapeutic Target
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1554231
Methods
Accepted on 02 Apr 2025
SAPrIm 2.0: A semi-automated protocol for midthroughput soluble HLA immunopeptidomics
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1546629
- 125 views
Review
Accepted on 02 Apr 2025
Neutrophil extracellular traps in diseases of the female reproductive organs
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1589329
- 140 views
Case Report
Accepted on 02 Apr 2025
Monoclonal gammopathy-associated C3 glomerulonephritis secondary to follicular lymphoma: a case report
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1551788